216 related articles for article (PubMed ID: 24310821)
1. Cardiac myosin binding protein-C: a novel sarcomeric target for gene therapy.
Mamidi R; Li J; Gresham KS; Stelzer JE
Pflugers Arch; 2014 Feb; 466(2):225-30. PubMed ID: 24310821
[TBL] [Abstract][Full Text] [Related]
2. E258K HCM-causing mutation in cardiac MyBP-C reduces contractile force and accelerates twitch kinetics by disrupting the cMyBP-C and myosin S2 interaction.
De Lange WJ; Grimes AC; Hegge LF; Spring AM; Brost TM; Ralphe JC
J Gen Physiol; 2013 Sep; 142(3):241-55. PubMed ID: 23980194
[TBL] [Abstract][Full Text] [Related]
3. A hypertrophic cardiomyopathy-associated MYBPC3 mutation common in populations of South Asian descent causes contractile dysfunction.
Kuster DW; Govindan S; Springer TI; Martin JL; Finley NL; Sadayappan S
J Biol Chem; 2015 Feb; 290(9):5855-67. PubMed ID: 25583989
[TBL] [Abstract][Full Text] [Related]
4. Molecular effects of the myosin activator omecamtiv mecarbil on contractile properties of skinned myocardium lacking cardiac myosin binding protein-C.
Mamidi R; Gresham KS; Li A; dos Remedios CG; Stelzer JE
J Mol Cell Cardiol; 2015 Aug; 85():262-72. PubMed ID: 26100051
[TBL] [Abstract][Full Text] [Related]
5. Amino terminus of cardiac myosin binding protein-C regulates cardiac contractility.
Lynch TL; Kumar M; McNamara JW; Kuster DWD; Sivaguru M; Singh RR; Previs MJ; Lee KH; Kuffel G; Zilliox MJ; Lin BL; Ma W; Gibson AM; Blaxall BC; Nieman ML; Lorenz JN; Leichter DM; Leary OP; Janssen PML; de Tombe PP; Gilbert RJ; Craig R; Irving T; Warshaw DM; Sadayappan S
J Mol Cell Cardiol; 2021 Jul; 156():33-44. PubMed ID: 33781820
[TBL] [Abstract][Full Text] [Related]
6. Cardiac myosin binding protein-C as a central target of cardiac sarcomere signaling: a special mini review series.
Sadayappan S; de Tombe PP
Pflugers Arch; 2014 Feb; 466(2):195-200. PubMed ID: 24196566
[TBL] [Abstract][Full Text] [Related]
7. Altered C10 domain in cardiac myosin binding protein-C results in hypertrophic cardiomyopathy.
Kuster DWD; Lynch TL; Barefield DY; Sivaguru M; Kuffel G; Zilliox MJ; Lee KH; Craig R; Namakkal-Soorappan R; Sadayappan S
Cardiovasc Res; 2019 Dec; 115(14):1986-1997. PubMed ID: 31050699
[TBL] [Abstract][Full Text] [Related]
8. Phosphorylation and function of cardiac myosin binding protein-C in health and disease.
Barefield D; Sadayappan S
J Mol Cell Cardiol; 2010 May; 48(5):866-75. PubMed ID: 19962384
[TBL] [Abstract][Full Text] [Related]
9. COOH-terminal truncated cardiac myosin-binding protein C mutants resulting from familial hypertrophic cardiomyopathy mutations exhibit altered expression and/or incorporation in fetal rat cardiomyocytes.
Flavigny J; Souchet M; Sébillon P; Berrebi-Bertrand I; Hainque B; Mallet A; Bril A; Schwartz K; Carrier L
J Mol Biol; 1999 Nov; 294(2):443-56. PubMed ID: 10610770
[TBL] [Abstract][Full Text] [Related]
10. Dissociation of structural and functional phenotypes in cardiac myosin-binding protein C conditional knockout mice.
Chen PP; Patel JR; Powers PA; Fitzsimons DP; Moss RL
Circulation; 2012 Sep; 126(10):1194-205. PubMed ID: 22829020
[TBL] [Abstract][Full Text] [Related]
11. In vivo definition of cardiac myosin-binding protein C's critical interactions with myosin.
Bhuiyan MS; McLendon P; James J; Osinska H; Gulick J; Bhandary B; Lorenz JN; Robbins J
Pflugers Arch; 2016 Oct; 468(10):1685-95. PubMed ID: 27568194
[TBL] [Abstract][Full Text] [Related]
12. Post-translational control of cardiac hemodynamics through myosin binding protein C.
Gupta MK; Robbins J
Pflugers Arch; 2014 Feb; 466(2):231-6. PubMed ID: 24145982
[TBL] [Abstract][Full Text] [Related]
13. Variable cardiac myosin binding protein-C expression in the myofilaments due to MYBPC3 mutations in hypertrophic cardiomyopathy.
Parbhudayal RY; Garra AR; Götte MJW; Michels M; Pei J; Harakalova M; Asselbergs FW; van Rossum AC; van der Velden J; Kuster DWD
J Mol Cell Cardiol; 2018 Oct; 123():59-63. PubMed ID: 30170119
[TBL] [Abstract][Full Text] [Related]
14. A Novel "Cut and Paste" Method for In Situ Replacement of cMyBP-C Reveals a New Role for cMyBP-C in the Regulation of Contractile Oscillations.
Napierski NC; Granger K; Langlais PR; Moran HR; Strom J; Touma K; Harris SP
Circ Res; 2020 Mar; 126(6):737-749. PubMed ID: 32078438
[TBL] [Abstract][Full Text] [Related]
15. Comparison of the effects of a truncating and a missense MYBPC3 mutation on contractile parameters of engineered heart tissue.
Wijnker PJ; Friedrich FW; Dutsch A; Reischmann S; Eder A; Mannhardt I; Mearini G; Eschenhagen T; van der Velden J; Carrier L
J Mol Cell Cardiol; 2016 Aug; 97():82-92. PubMed ID: 27108529
[TBL] [Abstract][Full Text] [Related]
16. Ablation of cardiac myosin-binding protein-C accelerates contractile kinetics in engineered cardiac tissue.
de Lange WJ; Grimes AC; Hegge LF; Ralphe JC
J Gen Physiol; 2013 Jan; 141(1):73-84. PubMed ID: 23277475
[TBL] [Abstract][Full Text] [Related]
17. Cardiac myosin-binding protein C: hypertrophic cardiomyopathy mutations and structure-function relationships.
Sequeira V; Witjas-Paalberends ER; Kuster DW; van der Velden J
Pflugers Arch; 2014 Feb; 466(2):201-6. PubMed ID: 24240729
[TBL] [Abstract][Full Text] [Related]
18. RLC phosphorylation amplifies Ca2+ sensitivity of force in myocardium from cMyBP-C knockout mice.
Turner KL; Morris HS; Awinda PO; Fitzsimons DP; Tanner BCW
J Gen Physiol; 2023 Apr; 155(4):. PubMed ID: 36715675
[TBL] [Abstract][Full Text] [Related]
19. Contractile abnormalities and altered drug response in engineered heart tissue from Mybpc3-targeted knock-in mice.
Stöhr A; Friedrich FW; Flenner F; Geertz B; Eder A; Schaaf S; Hirt MN; Uebeler J; Schlossarek S; Carrier L; Hansen A; Eschenhagen T
J Mol Cell Cardiol; 2013 Oct; 63():189-98. PubMed ID: 23896226
[TBL] [Abstract][Full Text] [Related]
20. N-terminal extension in cardiac myosin-binding protein C regulates myofilament binding.
Bunch TA; Lepak VC; Kanassatega RS; Colson BA
J Mol Cell Cardiol; 2018 Dec; 125():140-148. PubMed ID: 30359561
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
